5.94
Finanzdaten der Aura Biosciences Inc-Aktie (AURA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
22.18
|
- | 23.34 | 22.33 | 17.04 |
| Operating Income/Loss |
-27.91
|
- | -29.04 | -27.81 | -23.23 |
| Nonoperating Income/Loss |
1.802
|
- | 1.57 | 1.997 | 2.233 |
| Income/Loss From Continuing Operations Before Tax |
3.39%
-26.10
|
-27.02 | -27.46 | -25.81 | -21.00 |
| Income Tax Expense/Benefit |
0.026
|
- | 0.018 | 0.024 | 0.043 |
| Income/Loss From Continuing Operations After Tax |
3.29%
-26.13
|
-27.02 | -27.48 | -25.83 | -21.04 |
|
|
3.29%
-26.13
|
-27.02 | -27.48 | -25.83 | -21.04 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
65.94
|
- | 50.13 | 0.0956 | 49.66 |
| Diluted Average Shares |
65.94
|
- | 50.13 | 0.0956 | 49.66 |
| Basic Earnings Per Share |
-0.40
|
- | -0.55 | -0.52 | -0.42 |
| Diluted Earnings Per Share |
-0.40
|
- | -0.55 | -0.52 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):